Insmed to Present at Two October Conferences

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. CRWV
2. NVDA
3. SPY
4. BAC
5. BLK
6. CAT
7. AA
8. RKLB
9. RXRX
10. SPCX

Go back to Insmed to Present at Two October Conferences

Insmed (INSM) PT Raised to $35 at Credit Suisse Following FDA Approval of Arikayce

October 1, 2018 8:45 AM EDT

Credit Suisse analyst Martin Auster raised the price target on Insmed (NASDAQ: INSM) to $35.00 (from $33.00) while maintaining a Outperform rating following an FDA announcement that it has approved Arikayce for the treatment of refractory NTM MAC, in line with the FDA AdCom... More